Tamoxifen given in breast carcinoma for

Correct Answer: 5 years
Description: Women with hormone receptor-positive tumours will obtain a wohwhile benefit from at least 5 years of endocrine therapy, either 20 mg daily of tamoxifen if premenopausal or the Aromatase Inhibitors (anastrozole, letrozole, and exemestane) if postmenopausal. Recent trials have shown that longer durations of endocrine therapy provide a small extra benefit but with increased toxicity.It is no longer appropriate to give hormone therapy to women who do not have oestrogen or progesterone receptor-positive disease. Ref: Bailey and Love, 27e, page: 878
Category: Surgery
Share:

Get More
Subject Mock Tests

Practice with over 200,000 questions from various medical subjects and improve your knowledge.

Attempt a mock test now
Mock Exam

Take an exam with 100 random questions selected from all subjects to test your knowledge.

Coming Soon
Get More
Subject Mock Tests

Try practicing mock tests with over 200,000 questions from various medical subjects.

Attempt a mock test now
Mock Exam

Attempt an exam of 100 questions randomly chosen from all subjects.

Coming Soon
WordPress › Error

There has been a critical error on this website.

Learn more about troubleshooting WordPress.